Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-up
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tuberculosis (TB) survivors face significant long-term health issues, including increased comorbidities and persistent disability, 18-24 months after treatment. Integrating long-term care is crucial for managing these challenges in TB survivors.
Area Of Science
- Public Health
- Infectious Diseases
- Chronic Disease Management
Background
- National strategic plans for post-tuberculosis (TB) disability and comorbidities exist but lack documented feasibility.
- The added value of these plans in routine programmatic settings is underexplored.
Purpose Of The Study
- To assess the health status, ongoing symptoms, comorbidities, risk factors, and disability in individuals 18-24 months after completing TB treatment within a programmatic setting.
Main Methods
- Follow-up of 503 individuals who completed TB treatment at 11 Chinese health facilities (2022-2023).
- Assessment of health status, symptoms, comorbidities, risk factors, and disability (6-minute walking test [6MWT]).
Main Results
- Significant increases in cough, diabetes, hypertension, smoking, and alcohol consumption post-TB treatment.
- 27.0% remained disabled (6MWT<400m); 13% died or were lost-to-follow-up.
- Ongoing symptoms, hypertension, and undernutrition were risk factors for mortality/loss to follow-up.
Conclusions
- Tuberculosis survivors experience substantial multimorbidity and disability post-treatment.
- Health services require integrated long-term care strategies for TB survivors.
- Addressing ongoing health challenges is essential for TB aftercare.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
• Class zero: The individual has no known TB exposure and has a negative tuberculin skin test.
• Class one: The individual has been exposed to...
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
• Symptom Review: Chronic symptoms such as persistent cough, sputum production, shortness of breath (dyspnea), and episodes of exacerbation are...